{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04773",
    "Peptide Name": "BacZY05 (natural AMPs, bacteriocins; Gram-positive bacteria, prokaryotes)",
    "Source": "Bacillus subtilisZY05",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "MTSNHHAPYDLGYTRATMDRTKGSEARLSQSHKSVLSSDRSLQLDCVKLESLVIADQHA",
    "Sequence Length": 59,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 4,
    "Boman Index": 2.51,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "32%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Discovery: isolation, purification and de novo sequencing (partial) and genome mapping.Sequence analysis: APD analysis reveals that this sequence is unique and shows only very low similarity (30.65%) toBM173S: 15%; L: 12%. GRAVY: -0.627; mol Wt: 6557.327; mol formula: C276H451N85O93S3; mol ex coeff: 3042.5.Activity: active against S. aureus MTCC3103 (MIC 10.93 ug/ml), K. pneumoniae MTCC109 (MIC 10.93 ug/ml), S. typhi NCIM2501 (MIC 28.75 ug/ml), V. cholerae MTCC3909 (MIC 57.5 ug/ml), and E. coli DH5alpha (MIC 57.5 ug/ml). MBC are doubled. Activity also observed by diffusion assays (zone of inhibition). Est. 8/2024",
    "Author": "Chandrika K, Sachan A. 2024",
    "Reference": "World J Microbiol Biotechnol. 2024 Aug 2;40(9):287. doi: 10.1007/s11274-024-04093-w.PubMed",
    "Title": "Biosynthesis of bacteriocin BacZY05-silver nanoconjugates and evaluation of their antibacterial properties"
  },
  "3D Structure": []
}